These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

265 related items for PubMed ID: 25935673

  • 1. Mass-spectrometry-based method for screening of new peptide ligands for G-protein-coupled receptors.
    Cologna CT, Gilles N, Echterbille J, Degueldre M, Servent D, de Pauw E, Quinton L.
    Anal Bioanal Chem; 2015 Jul; 407(18):5299-307. PubMed ID: 25935673
    [Abstract] [Full Text] [Related]

  • 2. Ligand screening system using fusion proteins of G protein-coupled receptors with G protein alpha subunits.
    Suga H, Haga T.
    Neurochem Int; 2007 Jul; 51(2-4):140-64. PubMed ID: 17659814
    [Abstract] [Full Text] [Related]

  • 3. Development and application of hybrid structure based method for efficient screening of ligands binding to G-protein coupled receptors.
    Kortagere S, Welsh WJ.
    J Comput Aided Mol Des; 2006 Dec; 20(12):789-802. PubMed ID: 17054015
    [Abstract] [Full Text] [Related]

  • 4. Bioinformatics-based discovery and identification of new biologically active peptides for GPCR deorphanization.
    Colette J, Avé E, Grenier-Boley B, Coquel AS, Lesellier K, Puget K.
    J Pept Sci; 2007 Sep; 13(9):568-74. PubMed ID: 17694568
    [Abstract] [Full Text] [Related]

  • 5. Virtual screen for ligands of orphan G protein-coupled receptors.
    Bock JR, Gough DA.
    J Chem Inf Model; 2005 Sep; 45(5):1402-14. PubMed ID: 16180917
    [Abstract] [Full Text] [Related]

  • 6. Emerging concepts of guanine nucleotide-binding protein-coupled receptor (GPCR) function and implications for high throughput screening.
    Eglen RM, Bosse R, Reisine T.
    Assay Drug Dev Technol; 2007 Jun; 5(3):425-51. PubMed ID: 17638542
    [Abstract] [Full Text] [Related]

  • 7. Recognition of GPCRs by peptide ligands and membrane compartments theory: structural studies of endogenous peptide hormones in membrane environment.
    Sankararamakrishnan R.
    Biosci Rep; 2006 Apr; 26(2):131-58. PubMed ID: 16773462
    [Abstract] [Full Text] [Related]

  • 8. G protein-coupled receptor quantification using peptide group-specific enrichment combined with internal peptide standard reporter calibration.
    Eisen D, Planatscher H, Hardie DB, Kraushaar U, Pynn CJ, Stoll D, Borchers C, Joos TO, Poetz O.
    J Proteomics; 2013 Sep 02; 90():85-95. PubMed ID: 23500134
    [Abstract] [Full Text] [Related]

  • 9. Design and synthesis of cyclic and linear peptide-agarose tools for baiting interacting protein partners of GPCRs.
    Granier S, Jean-Alphonse F, Déméné H, Guillon G, Pascal R, Mendre C.
    Bioorg Med Chem Lett; 2006 Feb 02; 16(3):521-4. PubMed ID: 16289816
    [Abstract] [Full Text] [Related]

  • 10. High-mass MALDI-MS unravels ligand-mediated G protein-coupling selectivity to GPCRs.
    Wu N, Olechwier AM, Brunner C, Edwards PC, Tsai CJ, Tate CG, Schertler GFX, Schneider G, Deupi X, Zenobi R, Ma P.
    Proc Natl Acad Sci U S A; 2021 Aug 03; 118(31):. PubMed ID: 34326250
    [Abstract] [Full Text] [Related]

  • 11. Past, present and future of vasopressin and oxytocin receptor oligomers, prototypical GPCR models to study dimerization processes.
    Cottet M, Albizu L, Perkovska S, Jean-Alphonse F, Rahmeh R, Orcel H, Méjean C, Granier S, Mendre C, Mouillac B, Durroux T.
    Curr Opin Pharmacol; 2010 Feb 03; 10(1):59-66. PubMed ID: 19896898
    [Abstract] [Full Text] [Related]

  • 12. Extended template-based modeling and evaluation method using consensus of binding mode of GPCRs for virtual screening.
    Sato M, Hirokawa T.
    J Chem Inf Model; 2014 Nov 24; 54(11):3153-61. PubMed ID: 25350693
    [Abstract] [Full Text] [Related]

  • 13. Defining the ligand-binding site for vasopressin receptors: a peptide mimetic approach.
    Howl J, Parslow RA, Wheatley M.
    Biochem Soc Trans; 1995 Feb 24; 23(1):103-8. PubMed ID: 7758661
    [No Abstract] [Full Text] [Related]

  • 14. Extracellular loops and ligand binding to a subfamily of Family A G-protein-coupled receptors.
    Wheatley M, Simms J, Hawtin SR, Wesley VJ, Wootten D, Conner M, Lawson Z, Conner AC, Baker A, Cashmore Y, Kendrick R, Parslow RA.
    Biochem Soc Trans; 2007 Aug 24; 35(Pt 4):717-20. PubMed ID: 17635132
    [Abstract] [Full Text] [Related]

  • 15. Structure and Function of Peptide-Binding G Protein-Coupled Receptors.
    Wu F, Song G, de Graaf C, Stevens RC.
    J Mol Biol; 2017 Aug 18; 429(17):2726-2745. PubMed ID: 28705763
    [Abstract] [Full Text] [Related]

  • 16. Ligand-based peptide design and combinatorial peptide libraries to target G protein-coupled receptors.
    Gruber CW, Muttenthaler M, Freissmuth M.
    Curr Pharm Des; 2010 Aug 18; 16(28):3071-88. PubMed ID: 20687879
    [Abstract] [Full Text] [Related]

  • 17. Using silico methods predicting ligands for orphan GPCRs.
    Jiang Z, Zhou Y.
    Curr Protein Pept Sci; 2006 Oct 18; 7(5):459-64. PubMed ID: 17073696
    [Abstract] [Full Text] [Related]

  • 18. The Structural Basis of Peptide Binding at Class A G Protein-Coupled Receptors.
    Vu O, Bender BJ, Pankewitz L, Huster D, Beck-Sickinger AG, Meiler J.
    Molecules; 2021 Dec 30; 27(1):. PubMed ID: 35011444
    [Abstract] [Full Text] [Related]

  • 19. Sequence-derived three-dimensional pharmacophore models for G-protein-coupled receptors and their application in virtual screening.
    Klabunde T, Giegerich C, Evers A.
    J Med Chem; 2009 May 14; 52(9):2923-32. PubMed ID: 19374402
    [Abstract] [Full Text] [Related]

  • 20. Molecular mechanisms of ligand binding, signaling, and regulation within the superfamily of G-protein-coupled receptors: molecular modeling and mutagenesis approaches to receptor structure and function.
    Kristiansen K.
    Pharmacol Ther; 2004 Jul 14; 103(1):21-80. PubMed ID: 15251227
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 14.